Twist Reconciled Depreciation vs Ebitda Analysis

TWST Stock

USD 41.21 9.20 28.74%

Twist Bioscience financial indicator trend analysis is much more than just breaking down Twist Bioscience Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Twist Bioscience Corp is a good investment. Please check the relationship between Twist Bioscience Reconciled Depreciation and its Ebitda accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Reconciled Depreciation vs Ebitda

Reconciled Depreciation vs Ebitda Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Twist Bioscience Corp Reconciled Depreciation account and Ebitda. At this time, the significance of the direction appears to have pay attention.

The correlation between Twist Bioscience's Reconciled Depreciation and Ebitda is -0.77. Overlapping area represents the amount of variation of Reconciled Depreciation that can explain the historical movement of Ebitda in the same time period over historical financial statements of Twist Bioscience Corp, assuming nothing else is changed. The correlation between historical values of Twist Bioscience's Reconciled Depreciation and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Reconciled Depreciation of Twist Bioscience Corp are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Reconciled Depreciation i.e., Twist Bioscience's Reconciled Depreciation and Ebitda go up and down completely randomly.

Correlation Coefficient

-0.77

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Reconciled Depreciation

Ebitda

Most indicators from Twist Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Twist Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

At this time, Twist Bioscience's Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 1.28 in 2024, whereas Selling General Administrative is likely to drop slightly above 110.3 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	333.3M	296.6M	341.1M	170.8M
Cost Of Revenue	119.3M	155.4M	178.7M	187.6M

Total Operating Expenses Cost Of Revenue

Twist Bioscience fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory
Total Assets		0.9	0.7	0.99	0.94	0.27	0.91	0.89	0.65	-0.85	-0.93	0.94	0.93	0.87	0.83	0.26	-0.88	0.96	0.9	0.83	0.98	0.39	-0.75	-0.53	0.92	0.94
Short Long Term Debt Total	0.9		0.59	0.89	0.96	0.11	0.98	1.0	0.8	-0.76	-0.96	0.83	0.82	0.99	0.75	0.09	-0.84	0.84	0.98	0.97	0.9	0.32	-0.72	-0.45	0.98	0.97
Other Current Liab	0.7	0.59		0.7	0.64	0.02	0.57	0.62	0.05	-0.62	-0.56	0.72	0.64	0.61	0.32	0.01	-0.51	0.7	0.53	0.59	0.56	0.4	-0.41	-0.23	0.57	0.66
Total Current Liabilities	0.99	0.89	0.7		0.93	0.24	0.91	0.89	0.65	-0.84	-0.94	0.97	0.92	0.88	0.85	0.24	-0.89	0.95	0.9	0.84	0.98	0.4	-0.75	-0.54	0.92	0.94
Total Stockholder Equity	0.94	0.96	0.64	0.93		0.24	0.99	0.95	0.77	-0.82	-0.96	0.88	0.87	0.93	0.77	0.22	-0.93	0.93	0.97	0.89	0.92	0.48	-0.87	-0.65	0.99	0.98
Other Liab	0.27	0.11	0.02	0.24	0.24		0.15	0.03	0.22	-0.67	-0.13	0.29	0.57	0.0	0.43	1.0	-0.29	0.45	0.11	-0.08	0.23	-0.21	-0.23	-0.21	0.16	0.26
Net Tangible Assets	0.91	0.98	0.57	0.91	0.99	0.15		0.97	0.82	-0.76	-0.97	0.85	0.82	0.96	0.77	0.14	-0.91	0.88	0.99	0.93	0.92	0.44	-0.84	-0.61	1.0	0.97
Property Plant And Equipment Net	0.89	1.0	0.62	0.89	0.95	0.03	0.97		0.78	-0.72	-0.96	0.83	0.79	1.0	0.73	0.02	-0.83	0.81	0.97	0.99	0.89	0.33	-0.71	-0.44	0.98	0.96
Current Deferred Revenue	0.65	0.8	0.05	0.65	0.77	0.22	0.82	0.78		-0.56	-0.83	0.59	0.61	0.77	0.79	0.22	-0.78	0.61	0.85	0.75	0.75	0.19	-0.66	-0.49	0.84	0.77
Net Debt	-0.85	-0.76	-0.62	-0.84	-0.82	-0.67	-0.76	-0.72	-0.56		0.76	-0.87	-0.97	-0.7	-0.8	-0.66	0.78	-0.92	-0.73	-0.64	-0.79	-0.12	0.61	0.4	-0.77	-0.87
Retained Earnings	-0.93	-0.96	-0.56	-0.94	-0.96	-0.13	-0.97	-0.96	-0.83	0.76		-0.88	-0.83	-0.95	-0.85	-0.13	0.92	-0.87	-0.98	-0.92	-0.95	-0.39	0.76	0.52	-0.98	-0.96
Accounts Payable	0.94	0.83	0.72	0.97	0.88	0.29	0.85	0.83	0.59	-0.87	-0.88		0.92	0.83	0.86	0.31	-0.86	0.92	0.84	0.79	0.91	0.29	-0.67	-0.45	0.87	0.92
Cash	0.93	0.82	0.64	0.92	0.87	0.57	0.82	0.79	0.61	-0.97	-0.83	0.92		0.77	0.85	0.55	-0.81	0.95	0.8	0.72	0.89	0.17	-0.65	-0.43	0.83	0.91
Non Current Assets Total	0.87	0.99	0.61	0.88	0.93	0.0	0.96	1.0	0.77	-0.7	-0.95	0.83	0.77		0.72	-0.02	-0.8	0.79	0.96	0.99	0.87	0.29	-0.68	-0.41	0.96	0.95
Non Currrent Assets Other	0.83	0.75	0.32	0.85	0.77	0.43	0.77	0.73	0.79	-0.8	-0.85	0.86	0.85	0.72		0.45	-0.85	0.81	0.8	0.68	0.9	0.13	-0.56	-0.36	0.8	0.83
Other Assets	0.26	0.09	0.01	0.24	0.22	1.0	0.14	0.02	0.22	-0.66	-0.13	0.31	0.55	-0.02	0.45		-0.3	0.44	0.11	-0.09	0.23	-0.2	-0.22	-0.2	0.15	0.26
Long Term Debt	-0.88	-0.84	-0.51	-0.89	-0.93	-0.29	-0.91	-0.83	-0.78	0.78	0.92	-0.86	-0.81	-0.8	-0.85	-0.3		-0.91	-0.93	-0.74	-0.91	-0.58	0.82	0.64	-0.92	-0.9
Cash And Short Term Investments	0.96	0.84	0.7	0.95	0.93	0.45	0.88	0.81	0.61	-0.92	-0.87	0.92	0.95	0.79	0.81	0.44	-0.91		0.86	0.72	0.93	0.45	-0.78	-0.59	0.88	0.92
Net Receivables	0.9	0.98	0.53	0.9	0.97	0.11	0.99	0.97	0.85	-0.73	-0.98	0.84	0.8	0.96	0.8	0.11	-0.93	0.86		0.93	0.92	0.45	-0.78	-0.54	0.99	0.97
Good Will	0.83	0.97	0.59	0.84	0.89	-0.08	0.93	0.99	0.75	-0.64	-0.92	0.79	0.72	0.99	0.68	-0.09	-0.74	0.72	0.93		0.83	0.25	-0.63	-0.36	0.93	0.92
Common Stock Shares Outstanding	0.98	0.9	0.56	0.98	0.92	0.23	0.92	0.89	0.75	-0.79	-0.95	0.91	0.89	0.87	0.9	0.23	-0.91	0.93	0.92	0.83		0.39	-0.74	-0.52	0.93	0.93
Short Term Investments	0.39	0.32	0.4	0.4	0.48	-0.21	0.44	0.33	0.19	-0.12	-0.39	0.29	0.17	0.29	0.13	-0.2	-0.58	0.45	0.45	0.25	0.39		-0.62	-0.64	0.42	0.33
Long Term Debt Total	-0.75	-0.72	-0.41	-0.75	-0.87	-0.23	-0.84	-0.71	-0.66	0.61	0.76	-0.67	-0.65	-0.68	-0.56	-0.22	0.82	-0.78	-0.78	-0.63	-0.74	-0.62		0.94	-0.81	-0.74
Non Current Liabilities Total	-0.53	-0.45	-0.23	-0.54	-0.65	-0.21	-0.61	-0.44	-0.49	0.4	0.52	-0.45	-0.43	-0.41	-0.36	-0.2	0.64	-0.59	-0.54	-0.36	-0.52	-0.64	0.94		-0.57	-0.49
Capital Surpluse	0.92	0.98	0.57	0.92	0.99	0.16	1.0	0.98	0.84	-0.77	-0.98	0.87	0.83	0.96	0.8	0.15	-0.92	0.88	0.99	0.93	0.93	0.42	-0.81	-0.57		0.98
Inventory	0.94	0.97	0.66	0.94	0.98	0.26	0.97	0.96	0.77	-0.87	-0.96	0.92	0.91	0.95	0.83	0.26	-0.9	0.92	0.97	0.92	0.93	0.33	-0.74	-0.49	0.98

Click cells to compare fundamentals

Twist Bioscience Account Relationship Matchups

Twist Bioscience fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	398.9M	702.1M	961.4M	776.4M	892.9M	454.3M
Short Long Term Debt Total	36.0M	62.9M	94.9M	94.1M	108.2M	113.6M
Other Current Liab	2.6M	9.6M	53.5M	7.8M	9.0M	11.3M
Total Current Liabilities	36.0M	63.1M	90.7M	73.3M	84.3M	45.4M
Total Stockholder Equity	336.3M	580.8M	789.4M	623.4M	716.9M	752.8M
Other Liab	158K	351K	5.1M	60K	69K	65.6K
Net Tangible Assets	150.4M	334.8M	540.1M	789.4M	907.8M	953.2M
Property Plant And Equipment Net	59.2M	105.7M	214.4M	203.4M	233.9M	245.6M
Current Deferred Revenue	18.8M	28.8M	3.5M	36.6M	42.1M	44.2M
Net Debt	(57.7M)	(402.9M)	(283.8M)	(192.4M)	(173.2M)	(181.8M)
Retained Earnings	(458.5M)	(610.6M)	(828.4M)	(1.0B)	(929.7M)	(883.2M)
Accounts Payable	4.8M	14.9M	20.1M	14.1M	16.2M	10.5M
Cash	93.7M	465.8M	378.7M	286.5M	329.4M	194.1M
Non Current Assets Total	64.0M	155.6M	364.9M	352.1M	405.0M	425.2M
Non Currrent Assets Other	3.4M	9.2M	5.0M	8.5M	9.8M	5.2M
Other Assets	4.4M	3.4M	49.9M	(1K)	(1.2K)	(1.1K)
Cash And Short Term Investments	290.0M	477.9M	505.0M	336.4M	386.9M	267.6M
Net Receivables	26.4M	28.5M	40.3M	44.1M	50.7M	53.2M
Common Stock Shares Outstanding	39.2M	48.3M	53.9M	56.9M	65.4M	39.9M
Short Term Investments	196.3M	12.0M	126.3M	49.9M	57.4M	73.5M
Liabilities And Stockholders Equity	398.9M	702.1M	961.4M	776.4M	892.9M	454.3M
Non Current Liabilities Total	26.6M	58.2M	81.3M	79.6M	71.7M	90.3M
Capital Surpluse	470.4M	794.6M	1.2B	1.6B	1.9B	2.0B
Inventory	12.3M	31.8M	39.3M	32.1M	36.9M	38.7M
Other Current Assets	6.2M	8.3M	11.9M	11.7M	13.5M	14.1M
Other Stockholder Equity	794.6M	1.2B	1.6B	1.7B	1.9B	2.0B
Total Liab	62.6M	121.3M	172.0M	153.0M	137.7M	123.3M
Property Plant And Equipment Gross	59.2M	105.7M	214.4M	203.4M	233.9M	245.6M
Total Current Assets	334.9M	546.5M	596.5M	424.3M	487.9M	314.2M
Non Current Liabilities Other	25.2M	58.2M	60K	475K	546.3K	518.9K
Short Term Debt	9.7M	9.8M	13.6M	14.9M	17.1M	8.9M
Intangible Assets	307K	18.3M	59.7M	54.5M	62.7M	65.8M
Property Plant Equipment	20.8M	25.5M	44.1M	214.4M	246.5M	258.9M
Net Invested Capital	341.0M	1.6M	789.4M	623.4M	716.9M	752.8M

Twist Bioscience Investors Sentiment

The influence of Twist Bioscience's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Twist. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Twist Bioscience's public news can be used to forecast risks associated with an investment in Twist. The trend in average sentiment can be used to explain how an investor holding Twist can time the market purely based on public headlines and social activities around Twist Bioscience Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Twist Bioscience's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Twist Bioscience's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Twist Bioscience's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Twist Bioscience.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Twist Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Twist Bioscience's short interest history, or implied volatility extrapolated from Twist Bioscience options trading.

Currently Active Assets on Macroaxis

LAAC	Lithium Americas Corp
F	Ford Motor
CHPT	ChargePoint Holdings
AXL	American Axle Manufacturing
ICLN	iShares Global Clean

When determining whether Twist Bioscience Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Twist Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Twist Bioscience Corp Stock. Highlighted below are key reports to facilitate an investment decision about Twist Bioscience Corp Stock:

How To Invest In Twist

Details

Is Twist Stock a good investment?

Details

What is Twist Bioscience's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Twist Stock analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.

	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Global Correlations Find global opportunities by holding instruments from different markets
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance

Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.36)

Revenue Per Share

4.834

Quarterly Revenue Growth

0.251

Return On Assets

(0.16)

Return On Equity

(0.30)

The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Twist Reconciled Depreciation vs Ebitda Analysis

Reconciled Depreciation vs Ebitda

Reconciled Depreciation vs Ebitda Correlation Analysis

Correlation Coefficient

Reconciled Depreciation

Ebitda

Twist Bioscience fundamental ratios Correlations

Twist Bioscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Twist Bioscience fundamental ratios Accounts

Twist Bioscience Investors Sentiment

Currently Active Assets on Macroaxis

Complementary Tools for Twist Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Net	+ 1.0	Short Long Term Debt Total
Other Assets	+ 1.0	Other Liab
Capital Surpluse	+ 1.0	Net Tangible Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Liabilities	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Short Long Term Debt Total

Capital Surpluse	- 0.98	Retained Earnings
Net Receivables	- 0.98	Retained Earnings
Cash	- 0.97	Net Debt
Retained Earnings	- 0.97	Net Tangible Assets
Inventory	- 0.96	Retained Earnings
Retained Earnings	- 0.96	Property Plant And Equipment Net